Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novartis Ag ADR (NY: NVS )

104.87 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novartis Ag ADR

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
42 43 Next >
Specialty Pharmaceutical Market to Witness Massive Growth by 2028 : Pfizer, Roche, Amgen, AbbVie
Stay up-to-date with Specialty Pharmaceutical Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Exposures COVID-19
How To Relieve Stress - New Book, Invisible Stress By Award-Winning Author Sylvia Lafair: Kindle Version to Be Available at No Charge November 3-5, 2021
November 01, 2021 -- Sylvia Lafair is the founder of Creative Energy Options (CEOinc), a global business consulting firm and the world's leading authority in Pattern Breakthrough Leadership... 
Via 24-7 Press Release
Topics Lawsuit
Exposures Financial Legal
Therapeutic Radiopharmaceuticals Market May Set Epic Growth Story : Dongcheng, Q BioMed, Lantheus
Stay up-to-date with Therapeutic Radiopharmaceuticals Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Topics Supply Chain
Exposures Supply Chain
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... 
Via Benzinga
Exposures COVID-19
Novartis To Offload Its Stake Back To Roche For $20.7B
Novartis AG (NYSE: NVS), a shareholder in Roche Holdings AG (OTC: RHHBY) for more than 20 years, would sell its entire stake, which is nearly one-third voting... 
Via Benzinga
Earnings Scheduled For October 26, 2021
Companies Reporting Before The Bell • Veoneer (NYSE:VNE) is likely to report quarterly loss at $0.83 per share on revenue of $408.69 million. • Aarons (NYSE:AAN)... 
Via Benzinga
Energize – A First-of-Its-Kind Program to Increase Access to Renewable Energy for Pharmaceutical Suppliers
SOURCE: Novartis 
Via 3BL Media
Topics Emissions Supply Chain
Exposures Supply Chain
Novartis Inks $1.3B Protein Degradation Deal With UK's Dunad
The U.K.-based Dunad Therapeutics has entered a strategic collaboration and license agreement with Novartis AG (NYSE: NVS) to generate orally... 
Via Benzinga
FDA Approves Novartis' Scemblix In Two Chronic Myeloid Leukemia Settings
The FDA has approved Novartis AG's (NYSE: NVS) Scemblix (asciminib) for chronic myeloid leukemia (CML) in two distinct indications. The FDA granted... 
Via Benzinga
Exposures Product Safety
Tuesday Market Coverage
Thermo Electron fell on the publication of its social responsibility report today. 
Via Talk Markets
Novartis (NVS) Q3 2021 Earnings Call Transcript
NVS earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Skin Cancer Therapeutics Market to Witness Massive Growth by 2028 : Bristol Myers Squibb, Eli Lilly, Roche
Stay up-to-date with Skin Cancer Therapeutics Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Exposures COVID-19
Wazoku Continues Global Expansion After Strengthening Latin American Presence
The addition of the Channge crowd plus in-market team meets the needs of Wazoku's global clients and adds greater diversity to the existing InnoCentive crowd 
Via Newswire.com
Topics Stocks
Exposures US Equities
Novartis Boosts Guidance For These Key Drugs After Their Bang-Up Quarter
Novartis stock inched higher Tuesday after the company reported a mixed third quarter, but increased guidance for two drugs. 
Via Investor's Business Daily
Novartis: Q3 Earnings Insights
Novartis (NYSE:NVS) reported its Q3 earnings results on Tuesday, October 26, 2021 at 08:00 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Anaptys Sells Royalties Due On Cancer Drug Jemperli To Sagard For $250M... 
Via Benzinga
Novartis Mulls Strategic Options For Sandoz, Reaffirms FY21 Outlook
Novartis AG (NYSE: NVS) reported that its Q3 net income climbed 43% to $2.76 billion. EPS reached $1.23, up 45% Y/Y. Earnings: The Company posted a core EPS of $1.71,... 
Via Benzinga
Cyber Currency
Canadian stocks are particularly buoyant and not just in energy which is a riser today because the loony is up against the buck. 
Via Talk Markets
A Preview Of Novartis's Earnings
Novartis (NYSE:NVS) is set to give its latest quarterly earnings report on Tuesday, 2021-10-26. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Price To Earnings Ratio Insights For Novartis
In the current market session, Novartis Inc. (NYSE:NVS) is trading at $84.51, after a 0.19% decrease. However, over the past month, the stock increased by 1.91%, and... 
Via Benzinga
Global Pasireotide Market Market Overview and Forecast Report 2021:Novartis, ,
QY Research has made a brilliant attempt to elaborately and meticulously analyze the global Pasireotide market in its latest report. All of the market forecasts presented in the report are authentic... 
Via SBWire
Topics Initial Public Offering
Exposures Securities Market
Global Pasireotide Drugs Market Industry Professional 2021:Novartis, ,
QY Research has made a brilliant attempt to elaborately and meticulously analyze the global Pasireotide Drugs market in its latest report. All of the market forecasts presented in the report are... 
Via SBWire
Topics Initial Public Offering
Exposures Securities Market
Global Parkinsons Disease Drugs Market Market Development Overview 2021:Johnson & Johnson, Gilead Sciences, Pacira
QY Research has made a brilliant attempt to elaborately and meticulously analyze the global Parkinsons Disease Drugs market in its latest report. All of the market forecasts presented in the report are... 
Via SBWire
Topics Initial Public Offering
Exposures Securities Market
Global Parkinson's Disease (PD) Drugs Market Industry Chain Research Report 2021:Boehringer Ingelheim, GlaxoSmithKline, Novartis
QY Research has made a brilliant attempt to elaborately and meticulously analyze the global Parkinson's Disease (PD) Drugs market in its latest report. All of the market forecasts presented in the... 
Via SBWire
Topics Initial Public Offering
Exposures Securities Market
The Alliance for Regenerative Medicine Announces Election of 2022 Officers, Executive Committee, and Board of Directors
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Novartis Extends Fill/Finish Support For Pfizer/BioNTech COVID-19 Vaccines
Novartis AG (NYSE: NVS) has agreed to expand its fill-and-finish support for Pfizer Inc (NYSE: PFE) / BioNTech SE (NASDAQ: BNTX) COVID-19... 
Via Benzinga
Exposures COVID-19
Wednesday Market Coverage
Today gold rose again despite the active market for bitcoin and the lower Chinese demand for mine products like iron and coal. 
Via Talk Markets
The MDS Foundation Celebrates MDS World Awareness Day With Their 4th Annual Move for MDS 5k Walk at Boston Common and Virtually Around the World
Friendly Community Walks to Advance Awareness & Accelerate Research for Myelodysplastic Syndromes - a Rare Blood Cancer 
Via Newswire.com
Gene Therapy Market Worth $13.0 Billion by 2024 - Exclusive Report by MarketsandMarkets(TM)
Chicago, Illinois--(Newsfile Corp. - October 20, 2021) - According to the new market research report "Gene Therapy Market by Vectors... 
Via Newsfile
Pharma & Cosmetics Market to See Major Growth by 2026 : Roche, Novartis, Pfizer
2020-2029 Report on Global Pharma & Cosmetics Market by Player, Region, Type, Application and Sales Channel is latest research study released by HTF MI evaluating the market risk side analysis,... 
Via SBWire
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
42 43 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.